Loading...
Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites
BACKGROUND: Tamoxifen has dramatically reduced the recurrence and mortality rate of estrogen receptor positive breast cancer. However, the efficacy of tamoxifen varies between individuals and 40% of patients will have a recurrence despite adjuvant tamoxifen treatment. Factors that predict tamoxifen...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3880169/ https://ncbi.nlm.nih.gov/pubmed/24373320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-612 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|